BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11387236)

  • 1. An angiogenic laminin site and its antagonist bind through the alpha(v)beta3 and alpha5beta1 integrins.
    Ponce ML; Nomizu M; Kleinman HK
    FASEB J; 2001 Jun; 15(8):1389-97. PubMed ID: 11387236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of redundant angiogenic sites in laminin alpha1 and gamma1 chains.
    Ponce ML; Kleinman HK
    Exp Cell Res; 2003 May; 285(2):189-95. PubMed ID: 12706114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody.
    Sheu JR; Yen MH; Kan YC; Hung WC; Chang PT; Luk HN
    Biochim Biophys Acta; 1997 Oct; 1336(3):445-54. PubMed ID: 9367172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of endothelial cell binding sites on the laminin gamma 1 chain.
    Ponce ML; Nomizu M; Delgado MC; Kuratomi Y; Hoffman MP; Powell S; Yamada Y; Kleinman HK; Malinda KM
    Circ Res; 1999 Apr; 84(6):688-94. PubMed ID: 10189356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of cryptic sites in human and mouse laminins by rat osteoclasts is mediated by beta 3 and beta 1 integrins.
    Horton MA; Spragg JH; Bodary SC; Helfrich MH
    Bone; 1994; 15(6):639-46. PubMed ID: 7532981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple cell surface receptors for the short arms of laminin: alpha 1 beta 1 integrin and RGD-dependent proteins mediate cell attachment only to domains III in murine tumor laminin.
    Goodman SL; Aumailley M; von der Mark H
    J Cell Biol; 1991 May; 113(4):931-41. PubMed ID: 1827447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin recognition of different cell-binding fragments of laminin (P1, E3, E8) and evidence that alpha 6 beta 1 but not alpha 6 beta 4 functions as a major receptor for fragment E8.
    Sonnenberg A; Linders CJ; Modderman PW; Damsky CH; Aumailley M; Timpl R
    J Cell Biol; 1990 Jun; 110(6):2145-55. PubMed ID: 1693624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic peptide derived from the carboxy terminus of the laminin A chain represents a binding site for the alpha 3 beta 1 integrin.
    Gehlsen KR; Sriramarao P; Furcht LT; Skubitz AP
    J Cell Biol; 1992 Apr; 117(2):449-59. PubMed ID: 1560034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a potent peptide antagonist to an active laminin-1 sequence that blocks angiogenesis and tumor growth.
    Ponce ML; Hibino S; Lebioda AM; Mochizuki M; Nomizu M; Kleinman HK
    Cancer Res; 2003 Aug; 63(16):5060-4. PubMed ID: 12941835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix.
    Gronthos S; Simmons PJ; Graves SE; Robey PG
    Bone; 2001 Feb; 28(2):174-81. PubMed ID: 11182375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct and overlapping ligand specificities of the alpha 3A beta 1 and alpha 6A beta 1 integrins: recognition of laminin isoforms.
    Delwel GO; de Melker AA; Hogervorst F; Jaspars LH; Fles DL; Kuikman I; Lindblom A; Paulsson M; Timpl R; Sonnenberg A
    Mol Biol Cell; 1994 Feb; 5(2):203-15. PubMed ID: 8019006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha(v)beta3 and alpha(v)beta5 integrins bind both the proximal RGD site and non-RGD motifs within noncollagenous (NC1) domain of the alpha3 chain of type IV collagen: implication for the mechanism of endothelia cell adhesion.
    Pedchenko V; Zent R; Hudson BG
    J Biol Chem; 2004 Jan; 279(4):2772-80. PubMed ID: 14610079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of receptors binding fibronectin and laminin on fetal rat lung cells.
    Caniggia I; Liu J; Han R; Wang J; Tanswell AK; Laurie G; Post M
    Am J Physiol; 1996 Mar; 270(3 Pt 1):L459-68. PubMed ID: 8638739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of integrin-binding peptides in a laminin peptide library derived from the mouse laminin β chain short arm regions.
    Katagiri F; Takagi M; Nakamura M; Tanaka Y; Hozumi K; Kikkawa Y; Nomizu M
    Arch Biochem Biophys; 2014 May; 550-551():33-41. PubMed ID: 24785228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties.
    Maeshima Y; Colorado PC; Kalluri R
    J Biol Chem; 2000 Aug; 275(31):23745-50. PubMed ID: 10837460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix proteins via binding to multiple integrin receptors expressed on human hepatoma cells.
    Sheu JR; Lin CH; Peng HC; Huang TF
    Proc Soc Exp Biol Med; 1996 Oct; 213(1):71-9. PubMed ID: 8820826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of purified collagen receptors (alpha 1 beta 1, alpha 2 beta 1) and RGD-dependent integrins to laminins and laminin fragments.
    Pfaff M; Göhring W; Brown JC; Timpl R
    Eur J Biochem; 1994 Nov; 225(3):975-84. PubMed ID: 7525287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins.
    Sung V; Stubbs JT; Fisher L; Aaron AD; Thompson EW
    J Cell Physiol; 1998 Sep; 176(3):482-94. PubMed ID: 9699501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An IKLLI-containing peptide derived from the laminin alpha1 chain mediating heparin-binding, cell adhesion, neurite outgrowth and proliferation, represents a binding site for integrin alpha3beta1 and heparan sulphate proteoglycan.
    Tashiro K; Monji A; Yoshida I; Hayashi Y; Matsuda K; Tashiro N; Mitsuyama Y
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):119-26. PubMed ID: 10229666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.
    Kumar CC; Malkowski M; Yin Z; Tanghetti E; Yaremko B; Nechuta T; Varner J; Liu M; Smith EM; Neustadt B; Presta M; Armstrong L
    Cancer Res; 2001 Mar; 61(5):2232-8. PubMed ID: 11280792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.